Worth the risk. Public policy must change to encourage development of breakthrough drugs.
Davis
Kenneth
K
Mount Sinai Medical Center, New York, USA.
D015507:Drugs, Investigational; D006801:Humans; D010330:Patents as Topic; D011640:Public Policy; D014481:United States
D015507:Drugs, Investigational